Novo's pioneering diabetes pill beats Victoza, Januvia in tests

COPENHAGEN (Reuters) - Novo Nordisk's experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck& Co's Januvia and its own best-selling injectable treatment Victoza in tests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news